ALS-associated UBQLN2 mutations cluster within a proline-rich repeat (PRR) region and are known to decrease UBQLN2 solubility, promoting cytoplasmic aggregation and interfering with its normal function in protein quality control (Sharkey et al., 2018; Dao et al., 2018). Here, UBQLN2 is linked to amyotrophic lateral sclerosis.